Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-12 Purchase | 2024-12-16 2:28 pm | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 20,000 | $5.011 | $100,220 | 601,253 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-01 Tax Withholding | 2025-03-04 09:18 am | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 572 | $5.18 | 121,314 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 09:18 am | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,928 | $0 | 121,314 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 09:16 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO | 268 | $5.18 | 70,276 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 09:16 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO | 771 | $0 | 70,276 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-20 1:40 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 401 | $6.64 | 600,852 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:40 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 2,156 | $6.64 | 95,139 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:39 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 1,386 | $6.64 | 51,605 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:39 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 2,298 | $6.64 | 119,958 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:38 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO | 1,479 | $6.64 | 69,773 (Direct) | View |
| 2025-02-11 Tax Withholding | 2025-02-13 3:58 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,386 | $5.6 | 83,252 (Direct) | View |
| 2025-02-11 Exercise | 2025-02-13 3:58 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $0 | 83,252 (Direct) | View |
| 2025-02-02 Exercise | 2025-02-04 6:50 pm | 2025-02-02 2025-02-02 | OptimizeRx Corp | OPRX | KLEMA CATHY Director | 5,109 | $0 | 11,752 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 5:00 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 119,150 | $0 | 175,037 (Direct) | View |
| 2024-02-15 Option Award(A) | 2024-12-27 4:38 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 0 | $0 | 33,365 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 3:18 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 119,150 | $0 | 199,998 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 2:09 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 44,681 | $0 | 80,026 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 2:08 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 119,150 | $0 | 146,380 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 2:08 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 119,150 | $0 | 130,733 (Direct) | View |
| 2024-12-20 Tax Withholding | 2024-12-20 7:48 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,153 | $4.75 | 35,086 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 7:48 pm | 2024-12-19 2026-12-19 | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 3,927 | $0 | 35,086 (Direct) | View |
| 2024-12-19 Tax Withholding | 2024-12-20 7:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 2,576 | $4.75 | 93,941 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 7:47 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 6,546 | $0 | 93,941 (Direct) | View |
| 2024-12-19 Tax Withholding | 2024-12-20 7:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 577 | $4.75 | 15,511 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 7:47 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 1,964 | $0 | 15,511 (Direct) | View |
| 2024-12-19 Tax Withholding | 2024-12-20 7:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 1,316 | $4.75 | 47,761 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 7:46 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 5,237 | $0 | 47,761 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 09:37 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,785 | $0 | 24,456 (Direct) | View |
| 2024-11-08 Tax Withholding | 2024-11-12 09:37 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 524 | $6.27 | 24,456 (Direct) | View |
| 2024-11-01 Tax Withholding | 2024-11-05 8:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 1,693 | $5.15 | 35,345 (Direct) | View |
| 2024-10-11 Tax Withholding | 2024-10-15 4:53 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 2,066 | $6.63 | 33,366 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-15 4:53 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,222 | $0 | 33,366 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 16,622 | $0 | 43,793 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 4,177 | $7.83 | 43,793 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:26 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 6,649 | $0 | 29,844 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:26 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,952 | $7.83 | 29,844 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 6,649 | $0 | 83,527 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 2,617 | $7.83 | 83,527 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 3,324 | $0 | 13,521 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 976 | $7.83 | 13,521 (Direct) | View |
| 2024-08-02 Option Award | 2024-08-05 5:22 pm | 2025-08-02 2027-08-02 | OptimizeRx Corp | OPRX | McCarthy Brian Clark Chief Revenue Officer | 28,210 | $0 | 28,210 (Direct) | View |
Ownership | 2024-08-05 4:57 pm | N/A N/A | OptimizeRx Corp | OPRX | McCarthy Brian Clark Chief Revenue Officer | 0 | $0 | 0 (Direct) | View |
| 2024-04-18 Tax Withholding | 2024-06-12 11:41 am | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 782 | $9.35 | 639,043 (Direct) | View |
| 2024-04-18 Exercise | 2024-06-12 11:41 am | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 28,895 | $0 | 639,043 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:50 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 13,286 | $0 | 45,467 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:50 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 10,061 | $0 | 45,467 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:49 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 13,286 | $0 | 62,774 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:49 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 10,061 | $0 | 62,774 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:48 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 13,286 | $0 | 47,315 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:48 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 10,061 | $0 | 47,315 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:48 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 10,061 | $0 | 80,926 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:47 pm | N/A N/A | OptimizeRx Corp | OPRX | KLEMA CATHY Director | 6,643 | $0 | 6,643 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 13,286 | $0 | 68,044 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 10,061 | $0 | 68,044 (Direct) | View |
| 2024-05-02 Tax Withholding | 2024-05-06 9:35 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 35,415 | $10.7 | 72,846 (Direct) | View |
| 2024-05-02 Exercise | 2024-05-06 9:35 pm | 2024-05-02 2024-05-02 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 90,000 | $0 | 72,846 (Direct) | View |
| 2024-03-01 Exercise(A) | 2024-05-06 9:34 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,927 | $0 | 18,261 (Direct) | View |
| 2024-03-01 Tax Withholding(A) | 2024-05-06 9:34 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 572 | $15.95 | 18,261 (Direct) | View |
| 2024-02-15 Option Award(A) | 2024-05-06 9:32 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 7,750 | $0 | 16,906 (Direct) | View |
| 2024-02-15 Option Award | 2024-04-24 10:20 am | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 15,000 | $0 | 553,144 (Direct) | View |